LTβR 激动性通过调节瘤微环境促进抗瘤免疫反应
Disi An1, Guoying Chen1, Wei-Yi Cheng1
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Cancer research
|August 13, 2024
概括
淋巴毒素β受体 (LTβR) 信号传递促进瘤中高内皮静脉 (HEV) 和三级淋巴状结构 (TLS) 的形成. 这增强了T细胞的反应,提高了免疫治疗对抗癌症的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 瘤中的高内皮静脉 (HEV) 和三级淋巴体结构 (TLS) 与更好的预后和对免疫检查点阻塞的反应相关.
- 了解HEV和TLS形成的机制对于开发改进的癌症治疗是至关重要的.
- 淋巴毒素β受体 (LTβR) 信号传递是淋巴结器官生成的关键调节器,可以增强与瘤相关的HEV形成.
研究的目的:
- 研究LTβR信号在调节瘤微环境和促进抗瘤T细胞反应中的作用.
- 评估LTβR激素的潜力,作为一种增强癌症免疫疗法的策略.
主要方法:
- 系统激活LTβR通路使用异能抗体在综原性瘤模型中.
- 实验室研究评估LTβR对树突细胞 (DC) 和T细胞的激素作用.
- 在体内瘤查以识别TLS诱导的细胞因子与LTβR激素的结合.
主要成果:
- 诱导LTβR激素诱导了瘤特异性HEV形成,上调了TLS相关的化学激素,并增强了DC和T细胞的透和激活.
- LTβR的激进作用直接促进了DC的激活和成熟,导致DC介导的T细胞激活增强.
- 单剂LTβR激素治疗以CD8+T细胞和HEV依赖的方式抑制了瘤生长.
- 作为LTβR激动剂,增强了抗PD-1和CAR T细胞疗法的疗效.
- 结合LTβR激素和淋巴毒素的组合促进了瘤内TLS诱导和改善了抗CTLA4治疗反应.
结论:
- LTβR信号传递在调节瘤微环境中发挥着关键作用,以促进抗瘤免疫反应.
- LTβR激进作用诱导HEV形成并增强T细胞免疫力,支持其用于增强癌症免疫疗法.
- 针对LTβR信号提供了未来基于HEV/TLS的癌症治疗的有希望的策略.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861


